|
NYNRIN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.377670E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.570900E-04 |
| Normal-vs-Stage2 |
2.513200E-01 |
| Normal-vs-Stage3 |
3.290600E-01 |
| Normal-vs-Stage4 |
2.747400E-01 |
| Stage1-vs-Stage2 |
3.511400E-01 |
| Stage1-vs-Stage3 |
3.649600E-02 |
| Stage1-vs-Stage4 |
1.528430E-01 |
| Stage2-vs-Stage3 |
6.407800E-01 |
| Stage2-vs-Stage4 |
8.431800E-01 |
| Stage3-vs-Stage4 |
7.931000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.155900E-03 |
| Normal-vs-AfricanAmerican |
6.720400E-03 |
| Normal-vs-Asian |
2.737600E-02 |
| Caucasian-vs-AfricanAmerican |
7.872000E-02 |
| Caucasian-vs-Asian |
6.495600E-01 |
| AfricanAmerican-vs-Asian |
1.682420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.120200E-02 |
| Normal-vs-Female |
1.901460E-03 |
| Male-vs-Female |
7.038200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.279090E-03 |
| Normal-vs-Age(41-60Yrs) |
6.979400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.349800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.277800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.741000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.232400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.905000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.124200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.011560E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.075840E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.449650E-04 |
| Classical-VS-Follicular |
7.272100E-02 |
| Classical-VS-Other |
5.873400E-01 |
| Classical-VS-Normal |
4.42250000000088E-05 |
| Tall-VS-Follicular |
9.850100E-02 |
| Tall-VS-Other |
4.803800E-01 |
| Tall-VS-Normal |
3.043000E-01 |
| Follicular-VS-Other |
9.531400E-01 |
| Follicular-VS-Normal |
2.965800E-01 |
| Other-VS-Normal |
6.761400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.277200E-03 |
| Normal-vs-N1 |
6.406800E-01 |
| N0-vs-N1 |
1.032230E-01 |
|
|
